FMO5 and hypertensive disorder: In this study, we found that the NAD(P)H oxidase inhibitor VAS2870 improved endothelium-dependent arterial relaxations in SHR with Cont-shRNA, and it played similar roles as salusin-β knockdown in vascular relaxations in hypertension.